These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas. Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188 [TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Fishbein L; Nathanson KL Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592 [TBL] [Abstract][Full Text] [Related]
13. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163 [TBL] [Abstract][Full Text] [Related]
14. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior. Geli J; Kiss N; Karimi M; Lee JJ; Bäckdahl M; Ekström TJ; Larsson C Clin Cancer Res; 2008 May; 14(9):2551-9. PubMed ID: 18451216 [TBL] [Abstract][Full Text] [Related]
15. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Gimenez-Roqueplo AP; Dahia PL; Robledo M Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163 [TBL] [Abstract][Full Text] [Related]
16. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Vicha A; Musil Z; Pacak K Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210 [TBL] [Abstract][Full Text] [Related]
17. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P J Clin Endocrinol Metab; 2014 Jul; 99(7):E1352-60. PubMed ID: 24694336 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden. Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996 [TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene. Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258 [TBL] [Abstract][Full Text] [Related]